These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 6163417)
21. Interferon: pharmacokinetics and toxicity. Scott GM Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699 [TBL] [Abstract][Full Text] [Related]
22. Which will be the most useful interferon? Bocci V Ric Clin Lab; 1981; 11(1):27-32. PubMed ID: 6164090 [TBL] [Abstract][Full Text] [Related]
25. [Effect of interferon on the inhibition of malignant cell growth by human peripheral leukocytes. III. Effect of systemic administration]. Kita M; Imanishi J; Kishida T C R Seances Soc Biol Fil; 1981; 175(6):904-9. PubMed ID: 6173108 [TBL] [Abstract][Full Text] [Related]
26. Potentiation of warfarin by interferon. Adachi Y; Yokoyama Y; Nanno T; Yamamoto T BMJ; 1995 Jul; 311(7000):292. PubMed ID: 7543311 [No Abstract] [Full Text] [Related]
27. Toxicity of interferon. Priestman TJ; Lucken RN; Finter NB Br Med J (Clin Res Ed); 1981 Aug; 283(6290):562. PubMed ID: 6167311 [No Abstract] [Full Text] [Related]
28. [Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago]. Fehér J; Lengyel G Orv Hetil; 2007 Aug; 148(33):1539-43. PubMed ID: 17686671 [TBL] [Abstract][Full Text] [Related]
29. Antiproliferative assay for human interferons. Slimmer S; Masui H; Kaplan NO Methods Enzymol; 1981; 79(Pt B):419-22. PubMed ID: 6173689 [No Abstract] [Full Text] [Related]
30. Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo. Strander H; Cantell K In Vitro Monogr; 1974; (3):49-56. PubMed ID: 4471024 [No Abstract] [Full Text] [Related]
31. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Rubin BY; Gupta SL Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587 [TBL] [Abstract][Full Text] [Related]
32. [Human interferons -- features and chances (author's transl)]. Pohl A; Moser K; Micksche M Wien Klin Wochenschr; 1981 Jul; 93(14):439-57. PubMed ID: 6168122 [TBL] [Abstract][Full Text] [Related]
33. The interferon system as a basis for antiviral therapy or prophylaxis. Billiau A Verh K Acad Geneeskd Belg; 1986; 48(3):187-220. PubMed ID: 2430375 [No Abstract] [Full Text] [Related]
34. Interferon in cancer therapy. Neefe JR Am Fam Physician; 1981 Jul; 24(1):129-30. PubMed ID: 6167158 [No Abstract] [Full Text] [Related]
35. Pharmacokinetics and side effects of interferon in man. Merigan TC Tex Rep Biol Med; 1977; 35():541-7. PubMed ID: 358475 [No Abstract] [Full Text] [Related]
36. Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. Einhorn S; Strander H J Gen Virol; 1977 Jun; 35(3):573-7. PubMed ID: 267737 [TBL] [Abstract][Full Text] [Related]
37. Interferon treatment of human neoplasia. Strander H Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561 [No Abstract] [Full Text] [Related]
38. Pharmacokinetics of interferons. A reappraisal. Bocci V Tex Rep Biol Med; 1981-1982; 41():336-43. PubMed ID: 6184823 [No Abstract] [Full Text] [Related]
39. Prospects for the clinical use of exogenous interferon. Cantell K Med Biol; 1977 Apr; 55(2):69-73. PubMed ID: 194114 [TBL] [Abstract][Full Text] [Related]
40. Antagonism in action between mouse or human interferon and platelet growth factor. Inglot AD; Oleszak E; Kisielow B Arch Virol; 1980; 63(3-4):291-6. PubMed ID: 6243926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]